Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells
- PMID: 9422080
- DOI: 10.1159/000029972
Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells
Abstract
The dose-dependent alpha-fetoprotein (AFP) reactivity of different types of tumor cells and normal embryonal fibroblasts, which are capable of taking up AFP, was investigated. High doses (more than 100 micrograms/ml) of purified human AFP were shown to induce strongly dose-dependent growth inhibition of human hepatoma HepG2 cells, human lymphoblastoma MT4 cells, lymphoma Jurkat cells and murine fibroblastoma L929 cells. Human mammary carcinoma MCF-7 cells also revealed a growth inhibitory response to AFP, although to a lesser extent. Equivalent doses of human serum albumin (HSA) demonstrated no effect on these cells. On the contrary, normal embryonal fibroblasts of different organ origin showed dose-dependent stimulation (50-90%) of proliferation in response to AFP. A similar stimulative effect was obtained when embryonal fibroblasts were treated with the same doses of HSA. The myeloblastoma cell line U-937 and the normal epidermal fibroblast cell line M19 were shown to be resistant to the AFP action over a wide range of protein concentrations. It was demonstrated that growth factor deprivation (i.e. low serum concentration) could stimulate U-937 cell proliferation in response to high doses of AFP. It was also shown that intensive washing of U-937 and MCF-7 cells with fresh medium to remove secreted cytokines and growth factors distinctly increased cell sensitivity to high-dose-AFP-induced growth-inhibitory activity. Low AFP concentrations (less than 100 micrograms/ml) failed to induce growth inhibition in all studied cells and rather showed a slight stimulative effect. These findings demonstrate that physiological levels of AFP can exhibit a dose-dependent growth-regulatory activity toward sensitive tumor or developing cells. Our data demonstrated that AFP could reveal either stimulative or inhibitory growth activity, depending on the relative concentration of AFP and on exogenous or endogenous cytokines and growth factors in the cell culture medium. A growth-stimulative activity in normal embryonal fibroblasts and certain tumor cell lines exhibited by low AFP concentrations is supposed to result from the synergistic effects of AFP and various other secreted growth factors.
Similar articles
-
Induction of apoptosis in human hepatoma cells by alpha-fetoprotein.Tumour Biol. 1997;18(5):261-73. doi: 10.1159/000218039. Tumour Biol. 1997. PMID: 9276026
-
Synergistic action of purified alpha-fetoprotein and growth factors on the proliferation of porcine granulosa cells in monolayer culture.Endocrinology. 1991 Jul;129(1):217-25. doi: 10.1210/endo-129-1-217. Endocrinology. 1991. PMID: 1711460
-
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.Clin Cancer Res. 1998 Nov;4(11):2877-84. Clin Cancer Res. 1998. PMID: 9829755
-
Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics.Mol Cancer Ther. 2003 Nov;2(11):1243-55. Mol Cancer Ther. 2003. PMID: 14617798 Review.
-
Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.Immunol Commun. 1978;7(2):137-61. doi: 10.3109/08820137809033881. Immunol Commun. 1978. PMID: 77248 Review.
Cited by
-
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.World J Gastroenterol. 2005 May 7;11(17):2564-9. doi: 10.3748/wjg.v11.i17.2564. World J Gastroenterol. 2005. PMID: 15849812 Free PMC article.
-
Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.Cancer Sci. 2012 Aug;103(8):1493-501. doi: 10.1111/j.1349-7006.2012.02315.x. Epub 2012 May 25. Cancer Sci. 2012. PMID: 22530999 Free PMC article.
-
Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.Cancer Med. 2018 Jun;7(6):2691-2698. doi: 10.1002/cam4.1481. Epub 2018 Apr 25. Cancer Med. 2018. PMID: 29696820 Free PMC article.
-
ZHX2 is a repressor of alpha-fetoprotein expression in human hepatoma cell lines.J Cell Mol Med. 2008 Dec;12(6B):2772-80. doi: 10.1111/j.1582-4934.2008.00233.x. Epub 2008 Jan 11. J Cell Mol Med. 2008. PMID: 18194454 Free PMC article.
-
Establishment of an alpha-fetoprotein-producing cell line derived from gastric cancer.In Vitro Cell Dev Biol Anim. 1999 Nov-Dec;35(10):555-7. doi: 10.1007/s11626-999-0090-9. In Vitro Cell Dev Biol Anim. 1999. PMID: 10614861 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources